Background Leadless cardiac pacemakers (LCPMs) are an emerging alternative to TV-PM 1–
3 to reduce the complications related to TV leads and subcutaneous generator pockets. 4–6 …

Cardiac resynchronization therapy (CRT) was proposed in the 1990s as a new therapy for
patients with heart failure and wide QRS with depressed left ventricular ejection fraction …

Background Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) is
effective in patients with heart failure, left bundle branch block (LBBB), and reduced left …

Background Left ventricular (LV) endocardial pacing is a promising method to deliver
cardiac resynchronization therapy (CRT). WiSE-CRT is a wireless LV endocardial pacing …

Ultrasound‐powered implants (UPIs) represent cutting edge power sources for implantable
medical devices (IMDs), as their powering strategy allows for extended functional lifetime …

Aims Totally leadless cardiac resynchronization therapy (CRT) can be delivered with a
combination of Micra and WiSE-CRT systems. We describe the technical feasibility and first …

Despite the technological advances in pacemaker technology, the transvenous implanted
leads are still considered the Achilles' heel of this rhythm-control therapy. The leadless …

Background Biventricular endocardial pacing (BiV-endo) has demonstrated superior cardiac
resynchronization compared to conventional biventricular epicardial pacing (BiV-epi). Left …

Chronic kidney disease (CKD) is increasingly prevalent in patients with heart failure (HF)
and HF is one of the leading causes of hospitalisation, morbidity and mortality in patients …

Background The WiSE-CRT system delivers leadless endocardial left ventricular (LV)
pacing to achieve cardiac resynchronization therapy. The electrode is conventionally placed …